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doi:10.1016/j.jtcvs.2007.08.081494 The Journal of Thoracic and CarObjective: This study investigated the effects of a quality improvement program and
goal-oriented, multidisciplinary protocols on mortality after cardiac surgery.
Methods: Patients were divided into two groups: those undergoing surgery (coronary
artery bypass grafting, isolated valve surgery, or coronary artery bypass grafting and
valve surgery) after establishment of the multidisciplinary quality improvement pro-
gram (January 2005–December 2006, n 5 922) and those undergoing surgery before
institution of the program (January 2002–December 2003, n5 1289). Logistic regres-
sion and propensity score analysis were used to adjust for imbalances in patients’ pre-
operative characteristics.
Results: Operative mortality was lower in the quality improvement group (2.6%
vs 5.0%, P , .01). Unadjusted odds ratio was 0.5 (95% confidence interval
0.3–0.8, P, .01); propensity score–adjusted odds ratio was 0.6 (95% confidence in-
terval 0.4–0.99, P5 .04). In multivariable analysis, diabetes (P, .01), chronic renal
insufficiency (P5 .05), previous cardiovascular operation (P5 .04), congestive heart
failure (P , .01), unstable angina (P , .01), age older than 75 years (P , .01),
prolonged pump time (P , .01), and prolonged operation (P 5 .05) emerged as
independent predictors of higher mortality after cardiac surgery, whereas quality
improvement program (P , .01) and male sex (P 5 .03) were associated with
lower mortality. Mortality decline was less pronounced in patients with than without
diabetes (P 5 .04).
Conclusion: Application of goal-directed, multidisciplinary protocols and a quality
improvement program were associated with lower mortality after cardiac surgery.
This decline was less prominent in patients with diabetes, and focused quality
improvement protocols may be required for this subset of patients.
C
ardiothoracic surgery has a long history of commitment to improving the
quality of patient care. Data collection and critical analysis have established
high standards that may effectively decrease the rate of less acceptable out-
comes.1,2 Recently, The Society of Thoracic Surgeons’ executive committee created
the quality measurement task force, a comprehensive quality measurement program
for cardiothoracic surgery.2 Measurement of existing quality and identification of
substantial deviations from best practice are the first steps in any continuous quality
improvement program (QIP). Such an examination leads to focused interventions,
after which improvements are documented with repeated measurements.3
In contrast to the integral role that publication plays in scientific discovery, publi-
cation in medical quality improvement has unfortunately had only a limited role to
date. This lack of published reports has arguably deprived the health care system of
rigorous scholarly evidence on improvement work and thus has slowed advancement
of the improvement process.4,5 There is little evidence evaluating the effects on post-
operative mortality after cardiac surgery of implementing QIPs and quality measure-
ment.4,6-11diovascular Surgery c August 2008
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AVR 5 aortic valve replacement
CABG 5 coronary artery bypass grafting
QIP 5 quality improvement program
This study was conducted in a large clinical setting to eval-
uate systematically the effects on mortality after cardiac sur-
gery of the institution of a QIP and multidisciplinary protocols.
Materials and Methods
Patients
The computerized database of the Division of Cardiothoracic
Surgery at the Carolinas Heart Institute was used to select all patients
who underwent coronary artery bypass grafting (CABG), isolated
valve surgery, or valve surgery with CABG, in our institution
from January 2002 to December 2006. Patients were divided into
two groups: those who had surgery (CABG, isolated valve, or
both CABG and valve surgery) after the establishment of the multi-
disciplinary QIP (January 2005–December 2006, n 5 922) and
those undergoing surgery before the institution of the QIP (non-QIP,
January 2002–December 2003, n5 1289). Patients who underwent
surgery during the transitional year of 2004 were not included in the
analysis. The same group of cardiac surgeons, anesthesiologists, and
perfusionists performed all operations for both periods. Baseline de-
mographic characteristics, procedural data, and perioperative out-
comes were recorded and entered prospectively in a prespecified
database by a dedicated data-coordinating center.
Medical Ethics Approval
Study approval was sought and obtained from the investigational
review board at our institution. Confidentiality of personal patient
information was maintained at all times, consistent with the Health
Insurance Portability and Accountability Act of 1996 regulations.
Definitions
Previous cerebrovascular accident was defined as history of central
neurologic deficit persisting longer than 24 hours. Chronic renal
insufficiency was defined as a serum creatinine value of at least
2.0 mg/dL. Diabetes was defined as any history of diabetes mellitus,
regardless of duration of disease or need for oral agents or insulin.
Recent myocardial infarction was defined as myocardial infarction
occurring within 7 days before the surgery. Depressed ejection frac-
tion was defined as an ejection fraction less than 40%. Prolonged
ventilatory support was defined as pulmonary insufficiency requir-
ing ventilatory support for longer than 24 hours. Postoperative
stroke was defined as any new major (type II) neurologic deficit aris-
ing during hospitalization and persisting longer than 72 hours.12
Transient ischemic attacks were not included in this analysis.
Strokes were confirmed by an independent neurologist, appropriate
brain imaging, or both. Acute renal failure was defined as the in-
crease of serum creatinine to both greater than 2.0 mg/dL and greater
than twice the value of the most recent preoperative creatinine level.
Prolonged hospital stay was defined as hospital stay longer than the
75th percentile (9 days). Prolonged pump time and prolonged oper-
ative time were defined as pump and operative times longer than the
75th percentile (.125 min and.293 min, respectively). OperativeThe Journal of Thomortality included both (1) all deaths occurring during the hospital-
ization in which the operation was performed, even after 30 days,
and (2) those deaths occurring after discharge from the hospital
but within 30 days of the procedure, unless the cause of death was
clearly unrelated to the operation. The Society of Thoracic Surgeons
National Cardiac Database definitions were used for the purposes of
the study.
Quality Improvement Program
The QIP was begun in 2004 to improve cardiac surgical outcomes.
National trends toward increased acuity, aging patient populations,
and declining volumes, as well as goals of transparency, pay for
quality, and value-based competition, contributed to the impetus
for change. The Society of Thoracic Surgeons National Cardiac
Database and National Quality Forum metrics and guidelines3
focused our QIP. Evidenced-based intensive care unit management
protocols and guidelines included communication tools (standard-
ized handoff and goal sheets), sedation monitoring, respiratory pro-
tocols for early extubation and best pulmonary practices bundles,
computerized euglycemia management, blood management, and
an infection control program, (for detailed description of QIP proto-
cols, see online Appendix E). Multidisciplinary intensive care unit
rounds were a part of the QIP and included a nurse, charge nurse,
nurse practitioner, respiratory therapist, pharmacist, and cardiac
intensivist, as well as the cardiothoracic surgeons and residents.
Data analysis
Univariate comparisons of preoperative, operative, and postopera-
tive variables were performed between QIP and non-QIP groups.
Dichotomous variables were compared with a c2 test of general as-
sociation or a Fisher exact test for cell counts less than 5. All tests
were 2-sided. Some continuous variables had highly skewed distri-
butions. They were therefore converted to dichotomous variables,
and the upper 25th percentile was chosen as the cutoff point.
A multivariable, stepwise, backward logistic regression analysis
was conducted to determine independent predictors of operative
mortality. The criterion for a variable entry into the logistic model
was a univariate probability level of P , .05. The quality of the
fit of the logistic model was tested with the Hosmer–Lemeshow
goodness-of-fit test. All statistical analyses were conducted with
SAS software (SAS Institute, Inc, Cary, NC).
Propensity score adjustment was used on the postoperative out-
comes to correct for differences between QIP and non-QIP groups at
baseline. A logistic regression model was fitted where QIP or non-
QIP was the outcome and baseline characteristics (P , .l) from the
bivariate analysis were the covariates. Propensity scores were gen-
erated and included as regression (covariance) adjustments in each
of the logistic regression outcome models.13 The ability of the pro-
pensity score to balance effectively the compared groups at baseline
was confirmed with separate logistic models that used QIP or non-
QIP group type as the dependent variable and the covariate and
propensity score as the independent variables (online Appendix E).
Results
Preoperative Characteristics
Univariate comparisons between QIP (n5 922) and non-QIP
groups (n 5 1289) are presented in Table 1. QIP patients
were more likely to be male and to have hypertension,racic and Cardiovascular Surgery c Volume 136, Number 2 495
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CDchronic obstructive pulmonary disease (mild), and three-
vessel coronary artery disease than were non-QIP patients.
Non-QIP patients were more likely to be older; to be in
New York Heart Association functional class III or IV; and
to have lower ejection fraction, recent acute myocardial in-
farction, or unstable angina than were QIP patients; they
were also less likely to be operated on electively.
Operative and Postoperative Characteristics
Operative and postoperative patient characteristics are pre-
sented in Table 2. QIP patients were more likely to undergo
valve surgery or both CABG and valve surgery than were
non-QIP patients. Pump, operative, and crossclamp times
were more prolonged for QIP patients than for non-QIP
patients. QIP patients had lower rates of operative mortality,
postoperative sepsis, acute renal failure, and cardiac tampo-
nade than were non-QIP patients, and they were more likely
to be extubated within 6 hours after surgery. The reintubation







Male 684 (74%) 907 (70%) .05
Hypertension 724 (79%) 948 (74%) .01
Diabetes 342 (37%) 491 (38%) .63
Chronic renal insufficiency 50 (5%) 61 (5%) .46
Previous cerebrovascular accident 95 (10%) 136 (11%) .85
Chronic obstructive pulmonary disease .01
Mild 70 (8%) 94 (7%)
Moderate 21 (2%) 83 (6%)
Severe 34 (4%) 28 (2%)
None 797 (86%) 1084 (84%)
Previous cardiovascular operation 319 (35%) 482 (37%) .18
Congestive heart failure 153 (17%) 240 (19%) .22
Unstable angina 130 (14%) 324 (25%) .01
Recent myocardial infarction 154 (17%) 313 (24%) .01
Age .75 y 112 (12%) 190 (15%) .08
Ejection fraction ,40% 202 (22%) 349 (27%) .01
New York Heart Association functional class .01
I 45 (5%) 30 (2%)
II 390 (42%) 227 (18%)
III 347 (38%) 637 (49%)
IV 140 (15%) 395 (31%)
No. of diseased vessels .01
0 182 (20%) 133 (10%)
1 76 (8%) 61 (5%)
2 409 (44%) 887 (70%)
3 254 (28%) 195 (15%)
Case priority .01
Elective 315 (34%) 363 (28%)
Urgent 535 (58%) 789 (61%)
Emergency 72 (8%) 137 (11%)
All data represent numbers and percentages of patients. QIP, Quality
improvement program.496 The Journal of Thoracic and Cardiovascular Surgery c Augrate, however, was higher in the QIP group than in the
non-QIP group. No significant differences were found in pro-
longed ventilation, prolonged stay, mediastinitis, or hemor-
rhage-related reexploration.
Operative Mortality
Univariate analysis. In univariate analysis, operative
mortality was lower in the QIP group than in the non-QIP









Type of surgery .01
CABG 646 (70%) 1060 (82%)
Valve 195 (21%) 145 (11%)
CABG plus valve 81 (9%) 84 (7%)
Prolonged pump time (.125 min) 252 (27%) 286 (22%) .01
Prolonged crossclamp time
(.78 min)
258 (28%) 286 (22%) .01
Prolonged operative time
(.293 min)
244 (26%) 302 (23%) .12
Postoperative outcomes
Stroke 25 (3%) 21 (2%) .08
Sepsis 21 (2%) 50 (4%) .04
Renal failure 51 (6%) 105 (8%) .02
Atrial fibrillation 303 (33%) 349 (27%) .01
Hemodialysis 15 (2%) 27 (2%) .43
Cardiac arrest 20 (2%) 44 (3%) .09
Intra-aortic balloon pump 2 (0.2%) 2 (0.2%) ..999
Hemorrhage-related
reexploration
51 (6%) 85 (7%) .31
Blood transfusion 365 (40%) 526 (41%) .57
Cardiac tamponade 2 (0.2%) 20 (1.6%) .01
Mediastinitis 10 (1.1%) 8 (0.6%) .23
In-hospital mortality 20 (2%) 61 (5%) .01
Operative mortality 24 (3%) 65 (5%) .01
Cause of death
Cardiac 10 (42%) 45 (69%) .01
Infection 0 (0%) 2 (3%)
Stroke 4 (17%) 7 (11%)
Respiratory failure 5 (21%) 7 (11%)
Acute renal failure 1 (5%) 3 (5%)
Other 3 (13%) 1 (2%)
Unknown 1 (5%) 0 (0%)
Return to ICU 73 (8%) 108 (8%) .70
ICU stay ,24 h 295 (32%) 568 (44%) .01
Prolonged stay (.9 d) 210 (23%) 269 (21%) .28
Reintubation 65 (7%) 64 (5%) .04
Ventilation ,6 h 490 (53%) 490 (38%) .01
Prolonged intubation (.24 h) 88 (10%) 151 (12%) .11
All data represent numbers and percentages of patients. QIP, Quality
improvement program; CABG, coronary artery bypass grafting; ICU, inten-
sive care unit.ust 2008
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groups are presented in Table 2. It is apparent that the
decrease in operative mortality for QIP was almost entirely
attributable to a marked decrease in cardiac-related death.
Multivariate analysis. The results of the multivariable
logistic regression analysis are summarized in Table 3. The
C statistic for the model is 0.8, which indicates a good fit.
Diabetes (P , .01), chronic renal insufficiency (P 5 .05),
previous cardiovascular operation (P 5 .04), congestive
heart failure (P , .01), unstable angina (P , .01), age older
than 75 years (P, .01), prolonged pump time (P, .01), and
prolonged operative time (P 5 .05) emerged as independent
predictors of higher mortality after cardiac surgery.
QIP (P5 .04), male sex (P5 .03), and interaction of QIP
and nondiabetic status (P 5 .04) were associated with lower
mortality (Figure 1). There was a lower relative decline in
mortality among patients with diabetes than among those
without diabetes. For patients with diabetes, QIP and non-
QIP mortalities were 5% and 6%, respectively, whereas for
patients without diabetes, the respective values for QIP and
non-QIP groups were 2% and 5%.
Propensity score analysis. The propensity score–
adjusted odds ratio demonstrated a significant decrease in
mortality for the QIP group (odds ratio 0.6, 95% confidence
interval 0.4–0.99, P 5 .04). Figure 2 shows the general
decline of operative mortality with time.
Discussion
Cardiac surgery remains at the forefront of risk model devel-
opment and clinical quality monitoring. Recently, the Society
of Thoracic Surgeons created the Quality Measurement Task
Force to develop comprehensive summary quality measures
encompassing multiple domains of quality.14 Implementa-










QIP 20.29 0.14 0.6 0.3–1.0 .04
Male sex 20.26 0.14 0.6 0.4–0.9 .03
Diabetes 0.34 0.13 1.2 1.2–3.2 .01
Chronic renal
insufficiency
0.37 0.19 2.7 1.0–4.2 .05
Reoperation 0.24 0.12 1.6 1.0–2.5 .04
Congestive heart failure 0.51 0.12 2.8 1.8–4.5 .01
Unstable angina 0.40 0.14 2.2 1.3–3.8 .01
Age .75 y 0.41 0.13 2.3 1.3–3.6 .01
Prolonged pump time 0.46 0.14 2.5 1.4–4.2 .01
Prolonged operative time 0.27 0.14 1.7 1.0–3.0 .05
QIP and no diabetes 20.26 0.13 0.6 0.4–0.9 .04
QIP, Quality improvement program.The Journal of Thotion of the guidelines included in the report of the Quality
Measurement Task Force is expected to foster improvement
of outcomes. This study sought to investigate in a risk-
adjusted fashion whether a systematic and consistent imple-
mentation of a QIP would decrease mortality after cardiac
surgery.
Principal Findings
We demonstrated that a QIP and multidisciplinary protocols
are powerful tools associated with decreased mortality after
cardiac surgery. In our institution, mortality dropped almost
50% (from 5.0% to 2.6%); this decrease in operative mortality
for the QIP group was almost entirely attributable to a marked
decrease in cardiac-related deaths (Table 2). Specifically,
there was a decrease in the incidence of cardiac causes of
death by 30% in the QIP group relative to the non-QIP group.
This decline in operative mortality was made feasible by
the consistent application of multiple protocols, including
standardized communication tools and goal sheets, sedation
monitoring, respiratory protocols for early extubation and
best pulmonary practices bundles, computerized euglycemia
management, multidisciplinary intensive care unit rounds,
blood management, and an infection control program.
Predictors of Operative Mortality
In the multivariable analysis, well-documented risk factors
such as diabetes,15 female sex,16 renal insufficiency,17
reoperation,18 congestive heart failure, unstable angina,19 ad-
vanced age,20 prolonged pump time, and increased operative
time21 increased the risk of mortality in this study, as they
have done in other studies. The interaction of QIP and non-
diabetic status indicates that there were different modes of
Figure 1. Independent predictors of operative mortality after
cardiac surgery (multivariable logistic regression analysis). QIP,
Quality improvement program.racic and Cardiovascular Surgery c Volume 136, Number 2 497
Surgery for Acquired Cardiovascular Disease Stamou et alFigure 2. Graph demonstrating steady
decline in operative mortality with
time after institution of quality improve-
ment program (QIP). Gray line repre-
sents line of best fit.A
CDmortality decline for patients with and without diabetes.
More specifically, the mortality rate for patients with diabetes
was less affected by the process improvement initiatives, as
has been previously shown.22
Clinical Implications
For common surgical procedures, processes of care vary
widely among cardiac surgical programs. Important compo-
nents of a QIP program include a systems-based approach,
standardization, team building, consistent and accurate com-
munication, and active management of change and quality.
Use of composite indicators is useful to drive performance
improvement after cardiac surgery. This study, which dem-
onstrated a 48% decline in operative mortality after imple-
mentation of a QIP, is among the first to demonstrate such
a finding by the use of a rigorous risk-adjusted methodology
and a large sample size. The mortality decline with the QIP
was less pronounced for patients with diabetes, and future
improvement processes should focus on this particular subset
of patients.
Study Limitations
Limitations of this study include all those inherent in any ret-
rospective, single-institution analysis. This was a nonrandom-
ized study in which unmeasured patient or procedure-related
variables may have influenced the study results. Furthermore,
this investigation was conducted at a large tertiary referral
center, and the results may not be broadly representative of
community practice. Among the strengths of this study are
the large cohort of patients, the prospective entry of all data
elements into a cardiac surgical research database with strict
definitions, and analysis of data performed with appropriately
risk-adjusted statistical models to adjust for differences in
preoperative risk factors.498 The Journal of Thoracic and Cardiovascular Surgery c AugConclusions
The systematic and consistent implementation of a QIP in
conjunction with the application of multidisciplinary proto-
cols and quality improvement strategies decreased mortality
after cardiac surgery. This decrease in postoperative mortal-
ity was less pronounced in patients with diabetes, and future
quality improvement programs should focus on this high-risk
category.
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Unstable angina 0.01 0.98
Recent myocardial infarction 0.01 0.80
Age .75 years 0.08 0.89
Ejection fraction ,40 0.01 0.97
NYHA class 0.01 0.98
Three-vessel disease 0.01 0.99
Case priority 0.01 0.96
Type of surgery 0.01 0.99The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 2 499.e8
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